
	Summary Compensation Table Total			Compensation Actually Paid					Value of Initial Fixed $100 Investment Based On:
Fiscal Year	Carrie Eglinton Manner ($)1	Nancy Gagliano, M.D. ($)2	Stephen S. Tang, Ph.D. ($)3	Carrie Eglinton Manner ($)4	Nancy Gagliano, M.D. ($)4	Stephen S. Tang, Ph.D. ($)4	Average Summary Compensation Table Total for Non-PEO NEOs ($)5	Average Compensation Actually Paid to Non-PEO NEOs ($)6	Total Stockholder Return ($)7	Peer Group Total Stockholder Return ($)8	Net Income (Loss) (thousands) ($)9	Total Revenue (millions) ($)10
2023	6,701,767	—	—	13,791,592	—	—	1,600,748	2,390,906	102.12	106.34	53,655	405.5
2022	6,746,923	940,292	2,769,508	6,645,396	347,561	714,651	1,457,621	751,486	60.02	99.31	(17,934)	387.5
2021	—	—	2,959,781	—	—	2,697,616	1,088,815	808,537	108.22	125.43	(22,998)	233.7
2020	—	—	3,085,421	—	—	3,888,690	1,601,825	1,595,129	131.82	130.04	(14,922)	171.1

During fiscal year 2022, Ms. Eglinton Manner was appointed as our President and CEO effective June 4, 2022. Dr. Gagliano resigned effective June 4, 2022 from her position as the Company’s Interim CEO. During fiscal year 2022, Dr. Gagliano was appointed as our Interim CEO effective April 1, 2022 following Dr. Tang’s termination on March 31, 2022 and resigned from the position effective June 4, 2022. During fiscal years 2022, 2021 and 2020, Dr. Tang served as our President and CEO for all or a portion of the year. Dr. Tang’s employment with the Company as CEO ended on March 31, 2022. Our non-PEO NEOs includes the individuals indicated in the table below for each fiscal year:


			Year						Non-PEO NEOs
			2023						Kenneth McGrath, Kathleen Weber
			2022						Kenneth McGrath, Kathleen Weber, Lisa Nibauer, Agnieszka Gallagher, Scott Gleason
			2021						Kathleen Weber, Jack Jerrett, Roberto Cuca, Agnieszka Gallagher, Scott Gleason
			2020						Kathleen Weber, Jack Jerrett, Roberto Cuca, Anthony Zezzo, Lisa Nibauer

Adjustment To PEO Compensation, Footnote

Represents amounts of “compensation actually paid” to each of our CEO’s in each of 2023, 2022, 2021, and 2020 as computed in accordance with Item 402(v) of Regulation S-K, not the actual amount of compensation earned by or paid to each of our CEO’s during fiscal year 2023. The table below reflects the adjustments made from the amounts reported in the “Total” column of the Summary Compensation Table for each year to calculate the amounts set forth in “Compensation Actually Paid to PEO” column in the table above.


	Carrie Eglinton Manner		Nancy Gagliano, M.D.		Stephen S. Tang, Ph.D.
	2023 ($)	2022 ($)	2022 ($)		2022 ($)	2021 ($)(a)	2020 ($)(a)
Summary Compensation Table Total	6,701,767	6,746,923	940,292		2,769,508	2,959,781	3,085,421
Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year	(4,873,637)	(5,600,000)	(770,000)	(b)	(834,913)	(1,946,860)	(1,218,000)
Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year	8,377,123	5,498,473	—		—	1,337,758	1,799,376
Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years	3,488,559	—	(40,879)		—	132,795	237,531
Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year	—	—	218,148		664,350	—	—
Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year	97,780	—	—		(1,387,479)	214,142	(15,638)
Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year	—	—	—		(496,815)	—	—
Compensation Actually Paid to PEOs	13,791,592	6,645,396	347,561		714,651	2,697,616	3,888,690

(a)The fair values of time-based equity awards and performance-based restricted share units granted in 2020 are based on the closing price of the Company’s common shares as reported on the NASDAQ on the relevant valuation date. Performance-based restricted share units granted in 2021 were valued on the relevant valuation date using a Monte Carlo simulation model in accordance with the provisions of ASC Topic 718 using the following assumptions: (A) for valuations as of December 31, 2021, a risk free interest rate of 0.73% and share price volatility of 75.82%, for valuations on December 31, 2022, a risk free interest rate of 4.67% and share price volatility of 60.57%.” Note that the reference to valuations on December 31, 2022 is appropriate as this relates to the valuation of the 2021 PRUs as of December 31, 2022.

(b)Dr. Gagliano received, as part of her Interim CEO agreement, a sign-on equity grant consisting of $100,000 of fully vested shares (14,815 shares) and $670,000 of restricted stock units (99,259 restricted stock units) which vest in equal monthly installments beginning on April 30, 2022, subject to continued employment as Interim CEO. Dr. Gagliano vested in 24,815 units of the 99,259 restricted stock units granted prior to her resignation as Interim CEO in June 2022, and accordingly, 74,444 units of her restricted stock unit award were forfeited.

Non-PEO NEO Average Compensation Actually Paid Amount

$ 2,390,906

$ 751,486

808,537

1,595,129

Compensation Actually Paid vs. Total Shareholder Return

Compensation Actually Paid vs. Company Selected Measure

Tabular List, Table


			Important Financial Performance Measures
			Net Revenues
			Adjusted Operating Income
			Income Before Interest and Taxes
			Stock Price

Peer Group Total Shareholder Return Amount

106.34

99.31

125.43

130.04

Company Selected Measure Amount

405,500,000

387,500,000

233,700,000

171,100,000

Additional 402(v) Disclosure

For the relevant fiscal year, represents the cumulative total shareholder return (TSR) of OraSure Technologies, Inc. for the measurement periods ending on December 31 of each of 2023, 2022, 2021, and 2020, respectively. Reflects GAAP “Net Income (Loss)” in the Company’s Consolidated Statement of Operations included in the Company’s Annual Report on Form 10-K for each of the years ended December 31, 2023, 2022, 2021, and 2020. Represents “Net Revenues” in the Company’s Consolidated Statement of Operations included in the Company’s Annual Report on Form 10-K for each of the years ended December 31, 2023, 2022, 2021, and 2020.